Radiocontrast increases plasma and urinary endothelin.

Recent studies indicate that endothelin (ET), a potent endogenous systemic and renal vasoconstrictor peptide, may mediate decreases in GFR in models of acute renal dysfunction. Moreover, in an animal model of radiocontrast-induced nephropathy (RCIN), it was recently demonstrated that early renal hemodynamic responses to radiocontrast are attenuated by intra-arterial atrial natriuretic factor (ANF), which prevents subsequent RCIN. The studies presented here were therefore designed to determine whether i.v. infusion of radiocontrast produces increases in endogenous plasma and urinary ET and whether these responses are modulated by intra-arterial ANF in an animal model of RCIN. In these studies, dogs with pacing-induced heart failure received i.v. radiocontrast in the presence and absence of an intra-aortic infusion of ANF. Significant increases in both plasma and urinary ET were observed during and after radiocontrast. Although coadministration of ANF did not prevent increases in plasma and urinary ET, ANF preserved renal function acutely in this model of RCIN by increasing GFR above baseline levels.

[1]  A. Lerman,et al.  Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.

[2]  A. Ristimäki,et al.  Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. , 1990, Biochemical and biophysical research communications.

[3]  K. Margulies,et al.  Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. , 1990, Kidney international.

[4]  K. Margulies,et al.  Increased endothelin in experimental heart failure. , 1990, Circulation.

[5]  N. Perico,et al.  Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. , 1990, Journal of the American Society of Nephrology : JASN.

[6]  A. Davenport,et al.  Endothelin-1 mRNA is widely expressed in porcine and human tissues. , 1990, The Journal of clinical investigation.

[7]  H. Matsumoto,et al.  Pathophysiological role of endothelin in acute renal failure. , 1990, Life sciences.

[8]  M. Shichiri,et al.  Secretion of endothelin and related peptides from renal epithelial cell lines , 1989, FEBS letters.

[9]  A. Fogo,et al.  Glomerular actions of endothelin in vivo. , 1989, The Journal of clinical investigation.

[10]  R. Schrier,et al.  Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. , 1989, Kidney international.

[11]  J. Jamart,et al.  PREVENTION OF ACUTE CYCLOSPORINE NEPHROTOXICITY BY ATRIAL NATRIURETIC FACTOR AFTER ISCHEMIA IN THE RAT , 1989, Transplantation.

[12]  M. Redfield,et al.  Integrated cardiac, renal, and endocrine actions of endothelin. , 1989, The Journal of clinical investigation.

[13]  M. Brezis,et al.  Acute renal failure with selective medullary injury in the rat. , 1988, The Journal of clinical investigation.

[14]  R. Schrier,et al.  In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. , 1987, The Journal of clinical investigation.

[15]  L. Fisher,et al.  Risks for renal dysfunction with cardiac angiography. , 1986, Annals of internal medicine.

[16]  F. Laerum Acute damage to human endothelial cells by brief exposure to contrast media in vitro. , 1983, Radiology.

[17]  K. Mathias,et al.  The effect of contrast media on the aortic endothelium of rats. , 1983, Radiology.